Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8545-8557
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8545
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8545
Figure 4 Migration of pancreatic cancer cells was inhibited after gemcitabine and clobenpropit combination in wound healing assay.
The concentrations of gemcitabine in Panc-1 (A) and MiaPaCa-2 (B) were 5 and 15 μmol/L, respectively. The concentration of clobenpropit was 50 μmol/L. G: Gemcitabine; C: Clobenpropit.
- Citation: Paik WH, Ryu JK, Jeong KS, Park JM, Song BJ, Lee SH, Kim YT, Yoon YB. Clobenpropit enhances anti-tumor effect of gemcitabine in pancreatic cancer. World J Gastroenterol 2014; 20(26): 8545-8557
- URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8545.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8545